Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
Cancer Research
|
March 17, 2006
10th Biennial Helene Harris Memorial Trust meeting
Frances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Fertility and Sterility
|
June 13, 2022
Conception by fertility treatment and cardiometabolic risk in middle childhood
Edwina H Yeung, Pauline Mendola, Rajeshwari Sundaram, et al.
The American Journal of Clinical Nutrition
|
February 5, 2025
Relationship between gestational weight gain with fetal body composition and organ volumes in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Fetal Dimensional Study: a prospective pregnancy cohort
Kathryn A Wagner, Zhen Chen, Stefanie N Hinkle, et al.
British Journal of Cancer
|
March 20, 2014
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
R M Glasspool, R Brown, M E Gore, et al.
Human Gene Therapy
|
June 12, 1999
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma
K Palmer, J Moore, M Everard, et al.
Oncotarget
|
April 29, 2017
Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
Saeed Rafii, Charlie Gourley, Rajiv Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 9, 2017
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials
Angela George, Rebecca Kristeleit, Saeed Rafii, et al.
American Journal of Obstetrics and Gynecology
|
May 5, 2016
Dichorionic twin trajectories: the NICHD Fetal Growth Studies
Katherine L Grantz, Jagteshwar Grewal, Paul S Albert, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
BMJ Open
|
May 4, 2019
Diabetes & Women's Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark
Cuilin Zhang, Sjurdur F Olsen, Stefanie N Hinkle, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
Cancer Research
|
March 17, 2006
10th Biennial Helene Harris Memorial Trust meeting
Frances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Fertility and Sterility
|
June 13, 2022
Conception by fertility treatment and cardiometabolic risk in middle childhood
Edwina H Yeung, Pauline Mendola, Rajeshwari Sundaram, et al.
The American Journal of Clinical Nutrition
|
February 5, 2025
Relationship between gestational weight gain with fetal body composition and organ volumes in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Fetal Dimensional Study: a prospective pregnancy cohort
Kathryn A Wagner, Zhen Chen, Stefanie N Hinkle, et al.
British Journal of Cancer
|
March 20, 2014
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
R M Glasspool, R Brown, M E Gore, et al.
Human Gene Therapy
|
June 12, 1999
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma
K Palmer, J Moore, M Everard, et al.
Oncotarget
|
April 29, 2017
Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
Saeed Rafii, Charlie Gourley, Rajiv Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 9, 2017
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials
Angela George, Rebecca Kristeleit, Saeed Rafii, et al.
American Journal of Obstetrics and Gynecology
|
May 5, 2016
Dichorionic twin trajectories: the NICHD Fetal Growth Studies
Katherine L Grantz, Jagteshwar Grewal, Paul S Albert, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
BMJ Open
|
May 4, 2019
Diabetes & Women's Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark
Cuilin Zhang, Sjurdur F Olsen, Stefanie N Hinkle, et al.
Page
of 26